Huynh, W., Vucic, S., Menon, P., Rynders, A., Ho, K. S., Glanzman, R., & Hotchkin, M. T. (2021). Study protocol of RESCUE-ALS: A Phase 2, randomised, double-blind, placebo-controlled study in early symptomatic amyotrophic lateral sclerosis patients to assess bioenergetic catalysis with CNM-Au8 as a mechanism to slow disease progression. BMJ Publishing Group.
Style de citation Chicago (17e éd.)Huynh, William, Steve Vucic, Parvathi Menon, Austin Rynders, Karen S. Ho, Robert Glanzman, et Michael T. Hotchkin. Study Protocol of RESCUE-ALS: A Phase 2, Randomised, Double-blind, Placebo-controlled Study in Early Symptomatic Amyotrophic Lateral Sclerosis Patients to Assess Bioenergetic Catalysis with CNM-Au8 as a Mechanism to Slow Disease Progression. BMJ Publishing Group, 2021.
Style de citation MLA (8e éd.)Huynh, William, et al. Study Protocol of RESCUE-ALS: A Phase 2, Randomised, Double-blind, Placebo-controlled Study in Early Symptomatic Amyotrophic Lateral Sclerosis Patients to Assess Bioenergetic Catalysis with CNM-Au8 as a Mechanism to Slow Disease Progression. BMJ Publishing Group, 2021.